ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma.

Kevin D Courtney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.